Shopping Cart

Remove All
Your shopping cart is currently empty

Pamufetinib mesylate

Name: Pamufetinib mesylate
Brand: TargetMol
SKU: T13108L
Price: 50 USD
Availability: InStock
Rating: 4.5 (1 reviews)

TAS-115 mesylate is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase(IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively).

Catalog No. T13108LCas No. 1688673-09-7

Resource Download

Pamufetinib mesylate

Catalog No. T13108LCas No. 1688673-09-7

TAS-115 mesylate is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase(IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively).

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Pack Size	Price	Availability
2 mg	$95	5 days
5 mg	$197	5 days
50 mg	$747	1-2 weeks
100 mg	$1,240	1-2 weeks

Bulk & Custom

Add to Cart

Questions

Product Introduction

Bioactivity

Description	TAS-115 mesylate is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase(IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively).
Targets&IC50	MET (rat):32 nM , VEGFR2 (rat):30 nM
In vitro	TAS-115 powerfully suppresses the VEGF-dependent proliferation of HUVECs with IC50 of 0.019 μM as a VEGFR-targeted inhibitor and powerfully suppresses the proliferation of MET-amplified cancer cells with GI50 of 0.032-0.362 μM as a MET-targeted inhibitor. TAS-115 has much less toxicity in various normal cell lines when compared with other VEGFR-targeted kinase inhibitors[1].In PC-9 and HCC827 cells, Crizotinib and TAS-115 inhibit Met phosphorylation and reverse erlotinib resistance and VEGF production triggered by HGF [2].
In vivo	TAS-115 is administered daily for 6 weeks, and it can completely inhibit the progress of MET-inactivated tumors by blocking angiogenesis without toxicity, even at a serum-saturating dose of TAS-115. In MET-amplified human cancer–bearing mice, TAS-115 induces marked tumor shrinkage and prolonges survival [1].
Alias	TAS-115 mesylate, TAS-115 methanesulfonate

Chemical Properties

Molecular Weight	614.66
Formula	C₂₈H₂₇FN₄O₇S₂
Cas No.	1688673-09-7

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Solubility Information

DMSO: 75 mg/mL (122.02 mM), Sonication is recommended.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	1.6269 mL	8.1346 mL	16.2692 mL	81.3458 mL
5 mM	0.3254 mL	1.6269 mL	3.2538 mL	16.2692 mL
10 mM	0.1627 mL	0.8135 mL	1.6269 mL	8.1346 mL
20 mM	0.0813 mL	0.4067 mL	0.8135 mL	4.0673 mL
50 mM	0.0325 mL	0.1627 mL	0.3254 mL	1.6269 mL
100 mM	0.0163 mL	0.0813 mL	0.1627 mL	0.8135 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:

For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments

A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent

DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。

Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO TargetMol | reagent

(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.

Preparation method for in vivo formula: Take 50 μL DMSO TargetMol | reagent

main solution, add 300 μLPEG300 TargetMol | reagent

mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O TargetMol | reagent

mix well and clarify

For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

TAS115 MesylatePamufetinib mesylatePamufetinib MesylateTAS 115 MesylateTAS-115 Mesylate